Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease

J Infect Chemother. 2022 Feb;28(2):217-223. doi: 10.1016/j.jiac.2021.10.013. Epub 2021 Oct 20.

Abstract

Objectives: To alleviate the overflow of coronavirus disease 2019 (COVID-19) patients in hospitals, less invasive and simple criteria are required to triage the patients. We evaluated the relationship between COVID-19 severity and fatty liver on plain computed tomography (CT) scan performed on admission.

Methods: In this retrospective cohort study, we considered all COVID-19 patients at a large tertiary care hospital between January 31 and August 31, 2020. COVID-19 severity was categorized into severe (moderate and severe) and non-severe (asymptomatic and mild) groups, based on the Japanese National COVID-19 guidelines. Fatty liver was detected on plain CT scan. Multivariate logistic regression analysis was performed to evaluate factors associated with severe COVID-19.

Results: Of 222 patients (median age: 52 years), 3.2%, 58.1%, 20.7%, and 18.0% presented with asymptomatic, mild, moderate, and severe COVID-19, respectively. Although 59.9% had no fatty liver on plain CT, mild, moderate, and severe fatty liver occurred in 13.1%, 18.9%, and 8.1%, respectively. Age and presence of fatty liver were significantly associated with severe COVID-19.

Conclusion: Our study showed that fatty liver on plain CT scan on admission can become a risk factor for severe COVID-19. This finding may help clinicians to easily triage COVID-19 patients.

Keywords: COVID-19; Outcome; Pneumonia; Triage.

MeSH terms

  • COVID-19*
  • Fatty Liver*
  • Humans
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Tomography, X-Ray Computed